NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
16 hedge funds and large institutions have $1.07M invested in InVivo Therapeutics Holdings Corp in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$33K | |
| 2 | +$29.1K | |
| 3 | +$7K | |
| 4 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
+$2.33K |
Top Sellers
| 1 | -$172K | |
| 2 | -$4K | |
| 3 | -$2.36K | |
| 4 |
Morgan Stanley
New York
|
-$1.17K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$2 |